WHAT WE DO

  • DEVELOP TECHNICAL AND RESOURCE REQUIREMENTS for commercial plans necessary to advance biotechnology solutions

  • MANAGE PROOF-OF-CONCEPT PHASES and feasibility studies to generate platform-based prototype product candidates that can be spun-out in standalone companies

  • ADVISE MANAGEMENT TEAMS as private holding company of successfully spun-out stand-alone subsidiary and affiliate companies

WHY US?

OUR PASSION reflects our commitment to society to accelerate the development of transformative technologies for healthier people and a healthier planet.

OUR COMMITMENT to development of the best solutions for health is realized in the mindful insight and guidance we provide in collaboration with our partners and investors.

OUR EXPERIENCE driving R&D and commercial operations is extensive. Decades of industry experience informs our approach to investing in cutting edge genomic solutions to solve challenging problems and improve health outcomes.

OUR TEAM understands how to manage the interactions required to advance technologies from concept to commercial success. We focus on connecting the technology and resources necessary to advance from pre-seed to seed-funded product prototype stages through series raises for product development and commercial launch.

Stacks Image 1234

FOUNDERS

THE TEAM

Stacks Image 1275
TODD BIXBY
CO-FOUNDER & CHIEF EXECUTIVE OFFICER
Biotechnology developer, corporate strategist, life sciences and public health professional with over 20 years experience advancing biotechnologies to promote healthier communities and environments.  Worked to develop and deploy advanced technologies for human health, environmental health, biodefense and national security, sustainable food production, conservation, and consumer products.

Multi-disciplinary expertise in corporate strategy, business and corporate development, M&A diligence, technology analysis, new product development, basic and applied research, project management, marketing and communications, strategic alliances, and commercialization.

Reference summaries of previous experience with medical diagnostics and new product development.
Stacks Image 1289
TODD BIXBY
CO-FOUNDER &
CHIEF EXECUTIVE OFFICER
Biotechnology developer, corporate strategist, life sciences and public health professional with over 20 years experience advancing biotechnologies to promote healthier communities and environments.  Worked to develop and deploy advanced technologies for human health, environmental health, biodefense and national security, sustainable food production, conservation, and consumer products.

Multi-disciplinary expertise in corporate strategy, business and corporate development, M&A diligence, technology analysis, new product development, basic and applied research, project management, marketing and communications, strategic alliances, and commercialization.

Reference summaries of previous experiences medical diagnostics and new product development.

Stacks Image 1307
RICHARD EINSTEIN, PHD
CO-FOUNDER & CHIEF TECHNOLOGY OFFICER
Highly experienced executive in managing a diverse group of stakeholders and teams, including C-level executives, middle managers, investors, clinicians, academicians, and patient advocates, required for the execution of complex technical platforms, the generation of first product instance, and meaningful patient outcomes.

Over 30 years experience developing molecular technology platforms from concept to data validation in a variety of therapeutic areas and technologies including genomics, gene and cell therapies.
Stacks Image 1317
RICHARD EINSTEIN, PHD
CO-FOUNDER &
CHIEF TECHNOLOGY OFFICER
Highly experienced executive in managing a diverse group of stakeholders and teams, including C-level executives, middle managers, investors, clinicians, academicians, and patient advocates, required for the execution of complex technical platforms, the generation of first product instance, and meaningful patient outcomes.

Over 30 years experience developing molecular technology platforms from concept to data validation in a variety of therapeutic areas and technologies including genomics, gene and cell therapies.

Stacks Image 1328
GAVIN HANEY
CO-FOUNDER & PRINCIPAL ADVISOR, COMMERCIAL STRATEGY
More than 20 years of successful results in biotechnology sales and marketing across molecular diagnostics for infectious disease, prenatal, ophthalmology and oncology.

Deep experience in a broad array of commercial roles of increasing responsibility including strategic partnerships, product development, clinical validation, reimbursement strategy, product launches, KOL engagement, medical education programs, sales operations and leading high performing sales and marketing teams.
Stacks Image 1337
GAVIN HANEY
CO-FOUNDER & PRINCIPAL ADVISOR,
COMMERCIAL STRATEGY
More than 20 years of successful results in biotechnology sales and marketing across molecular diagnostics for infectious disease, prenatal, ophthalmology and oncology.

Deep experience in a broad array of commercial roles of increasing responsibility including strategic partnerships, product development, clinical validation, reimbursement strategy, product launches, KOL engagement, medical education programs, sales operations and leading high performing sales and marketing teams.

Stacks Image 1349
DAVID SIMMS
CO-FOUNDER & PRINCIPAL ADVISOR, BUSINESS ANALYTICS
A business development leader with extensive experience in emerging technology projects, market analyses, and capital investment activities. His work experience includes creating business cases for environmental biotech and cleantech ventures, supporting multiple Department of Defense contracts, and working at the Centers for Disease Control and Prevention (CDC). He holds an MS in Biotechnology and an MBA from Johns Hopkins University.
Stacks Image 1359
DAVID SIMMS
CO-FOUNDER & PRINCIPAL ADVISOR,
BUSINESS ANALYTICS
A business development leader with extensive experience in emerging technology projects, market analyses, and capital investment activities. His work experience includes creating business cases for environmental biotech and cleantech ventures, supporting multiple Department of Defense contracts, and working at the Centers for Disease Control and Prevention (CDC). He holds an MS in Biotechnology and an MBA from Johns Hopkins University.

MANAGEMENT EXPERTISE

Stacks Image 1527
Proven track record of commercial success with over 80 years of combined experience with diagnostic and therapeutic development, as well as, first-in-class product launches
Obtained FDA approvals for molecular diagnostics (PMA, BLA, 510k, EUA), as well as, development of numerous first-in-class biotechnologies regulated by EPA and USDA
Pioneered novel companion and molecular diagnostics, in addition to applications employing genetic and genome engineering for precision medicine, public health interventions and food technologies
Experts at design and development to meet FDA, CE and ISO 9001 guidelines through research feasibility, clinical validation, manufacturing scale up and commercial product launch
Developed and validated commercial business cases for technology-based investment opportunities for biotechnology companies and the Department of Defense (DoD)
Established relationships with leaders in industry, academia, and government, in addition to subject matter experts, physician key opinion leaders and other influencers
Stacks Image 1393
Learn more about investment and collaboration opportunities here.
Stacks Image 1236